Snowball logo
logo
BRSY_logo

BrainsWay Ltd

BRSYF • PINK
$11.00$0.00  (0%)
Estimate
P/E
47.8
EPS
0.23
Beta
0.079
Growth
Revenue, YoY
34.65%
Net income, YoY
32.93%
FCF, YoY
-50.83%
About the company
Ticker
BRSYF
ISIN
Country
Israel
Sector (GICS)
Healthcare
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

Frequently asked questions

What sector does BrainsWay Ltd (BRSYF) operate in?

BrainsWay Ltd belongs to the Healthcare sector and operates in the Medical Devices industry.

What is BrainsWay Ltd (BRSYF) current stock price?

As of the latest data, BrainsWay Ltd stock price is $11.00, with a previous close of $11.00.

What is BrainsWay Ltd (BRSYF) current market capitalization?

BrainsWay Ltd market cap is approximately 442.78 million.

What is BrainsWay Ltd (BRSYF) Earnings Per Share (EPS)?

The trailing EPS is $0.23.

What is BrainsWay Ltd (BRSYF) Price-to-Earnings (P/E) ratio?

BrainsWay Ltd current P/E ratio is 47.83.

What is BrainsWay Ltd (BRSYF) EBITDA?

BrainsWay Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 2.82 million.

Does BrainsWay Ltd (BRSYF) pay dividends?

No. BrainsWay Ltd does not pay a dividend.

What is BrainsWay Ltd (BRSYF) beta (volatility) score?

BrainsWay Ltd has a beta of 0.079, indicating lower volatility than the overall market.